Protective effect of leflunomide on the natural course of Leishmania major-induced disease in genetically susceptible BALB/c mice
- 1 June 1995
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 17 (6) , 481-488
- https://doi.org/10.1016/0192-0561(95)00028-z
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomideAnnals of Hematology, 1994
- Cytokines in Leishmaniasis: A Complex Network of Stimulatory and Inhibitory InteractionsImmunobiology, 1993
- Natural killer cells participate in the early defense against Leishmania major infection in miceEuropean Journal of Immunology, 1993
- Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasisImmunology Today, 1993
- Effects of leflunomide (HWA 486) on expression of lymphocyte activation markersInflammation Research, 1993
- LEFLUNOMIDE, A NOVEL IMMUNOSUPPRESSIVE AGENTTransplantation, 1993
- Recombinant interleukin 12 cures mice infected with Leishmania major.The Journal of Experimental Medicine, 1993
- Immunology of LeishmaniasisAdvances in Parasitology, 1993
- Immunology of leishmaniasisCurrent Opinion in Immunology, 1992
- Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor‐α production by macrophages is induced by the synergistic action of interferon (IFN)‐γ and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN‐γ and IL 4European Journal of Immunology, 1991